Abstract

Objective Artificial intelligence-powered screening systems of coronavirus disease 2019 (COVID-19) are urgently demanding since the ongoing outbreak of SARS-CoV-2 worldwide. Chest CT or X-ray is not sufficient to support the large-scale screening of COVID-19 because mildly-infected patients do not have imaging features on these images. Therefore, it is imperative to exploit supplementary medical imaging strategies. Traditional Chinese medicine has played an essential role in the fight against COVID-19. Methods In this paper, we conduct two kinds of verification experiments based on a newly-collected multi-modality dataset, which consists of three types of modalities: tongue images, chest CT scans, and X-ray images. First, we study a binary classification experiment on tongue images to verify the discriminative ability between COVID-19 and non-COVID-19. Second, we design extensive multimodality experiments to validate whether introducing tongue image can improve the screening accuracy of COVID-19 based on chest CT or X-ray images. Results Tongue image screening of COVID-19 showed that the accuracy (ACC), sensitivity (SEN), specificity (SPEC), and Matthew correlation coefficient (MCC) of the improved AlexNet and Googlenet both reached 98.39%, 98.97%, 96.67%, and 99.11%. The fusion of chest CT and tongue images used a tandem multimodal classifier fusion strategy to achieve optimal classification, and the results and screening accuracy of COVID-19 reached 98.98%, resulting in a significant improvement of 4.75% the highest accuracy in 375 years compared with the single-modality model. The fusion of chest x-rays and tongue images also had good classification accuracy. Conclusions Both experimental results demonstrate that tongue image not only has an excellent discriminative ability for screening COVID-19 but also can improve the screening accuracy based on chest CT or X-rays. To the best of our knowledge, it is the first work that verifies the effectiveness of tongue image on screening COVID-19. This paper provides a new perspective and a novel solution that contributes to large-scale screening toward fast stopping the pandemic of COVID-19.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.